KR20160109868A - Emulsified cosmetic composition having a pH buffer system - Google Patents

Emulsified cosmetic composition having a pH buffer system Download PDF

Info

Publication number
KR20160109868A
KR20160109868A KR1020150035050A KR20150035050A KR20160109868A KR 20160109868 A KR20160109868 A KR 20160109868A KR 1020150035050 A KR1020150035050 A KR 1020150035050A KR 20150035050 A KR20150035050 A KR 20150035050A KR 20160109868 A KR20160109868 A KR 20160109868A
Authority
KR
South Korea
Prior art keywords
acid
skin
cosmetic composition
buffer system
organic
Prior art date
Application number
KR1020150035050A
Other languages
Korean (ko)
Other versions
KR102078140B1 (en
Inventor
나철희
원보미
한종섭
박선규
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020150035050A priority Critical patent/KR102078140B1/en
Priority to PCT/KR2016/002341 priority patent/WO2016148434A1/en
Priority to CN201680015173.8A priority patent/CN107427429B/en
Publication of KR20160109868A publication Critical patent/KR20160109868A/en
Priority to HK18103801.3A priority patent/HK1244226A1/en
Application granted granted Critical
Publication of KR102078140B1 publication Critical patent/KR102078140B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

The present invention relates to an emulsified cosmetic composition having a pH buffer system. According to the present invention, the cosmetic composition having a pH buffer system shows reduced stimulation by organic acid, continuously relieves the change of skin pH due to internal/external causes, and significantly improves the conditions of skin with problems such as aging, acne, and atopic dermatitis, through the improvement of skin barriers and the exfoliating of dead skin cells.

Description

pH 완충 시스템을 갖는 유화 화장료 조성물 {Emulsified cosmetic composition having a pH buffer system}[0001] The present invention relates to an emulsified cosmetic composition having a pH buffer system,

본 발명은 pH 완충 시스템을 갖는 유화 화장료 조성물에 관한 것이다.
The present invention relates to an emulsified cosmetic composition having a pH buffering system.

일반적으로 피부의 pH(산도)는 약산성으로, 약산성의 피부 pH는 피부의 세린프로테아제(Serine protease), 베타-글루코세레브로시다아제(beta-glucocerebrosidase) 등 정상적인 피부기능을 유지하는 효소들의 활성과 연관이 있다. 노화된 피부뿐만 아니라 여드름, 아토피를 비롯한 트러블이 발생한 피부의 대부분에서 정상보다 높은 피부 pH를 보이는 것을 확인할 수 있으며, 선행문헌 1,2 에 의하면 아토피 피부 및 노화된 피부에 낮은 pH의 물질을 처리함으로써 피부 장벽이 회복되고 피부가 정상화되는 것을 확인할 수 있다.In general, the pH (acidity) of the skin is mildly acidic, and the weakly acidic skin pH is related to the activity of enzymes that maintain normal skin function, such as serine protease and beta-glucocerebrosidase . It can be confirmed that most of the skin including troubles such as acne and atopy has a higher skin pH than the aged skin, and according to the prior arts 1 and 2, atopic skin and aged skin are treated with a low pH substance The skin barrier is restored and the skin is normalized.

그러나, 종래의 산성 pH 시스템의 경우 아토피 또는 트러블로 인해 손상되거나 민감해진 피부에 적용하는 경우 피부자극을 야기할 수 있는 문제가 있으며, 그 효과가 일시적이어서 피부상태의 본질적인 개선이 어렵고 소비자가 원하는 효능을 제공하기 어려운 문제가 있다.However, in the case of the conventional acidic pH system, there is a problem that it may cause skin irritation when it is applied to skin damaged or sensitized due to atopy or trouble, and it is difficult to improve the skin condition because the effect is temporary, There is a problem that is difficult to provide.

유기산은 각질층의 연결고리를 느슨하게 하여 과잉의 각질의 박리를 돕는 역할을 한다. 일반적으로 피부 각질층은 물리적, 화학적인 요인들로부터 피부를 보호하는 기능을 하고 있으며, 피부 세포의 지속적인 생성과 각질층에서의 박리로 진행되는 턴오버(Turn over)를 통해 깨끗하고 맑은 피부를 항시 유지할 수 있다. 하지만 노화, 자외선 또는 스트레스로 인한 환경적 요인으로 인해 자연적인 각질탈락이 지연되어 각질이 쌓이게 되면 피부 윤기가 감소하게 되고, 여드름 등의 피부 트러블이 가속될 수 있다. 각질 박리를 촉진시키는 유기산으로 알파 하이드록시산, 베타 하이드록시산, 폴리하이드록시산 등이 알려져 있다. Organic acid loosens the strands of the stratum corneum and helps to exfoliate excess keratin. Generally, the skin stratum corneum protects the skin from physical and chemical factors. It can keep the skin clean and clear all the time through the continuous production of skin cells and turn over which is caused by peeling in the stratum corneum. have. However, due to environmental factors such as aging, ultraviolet rays, or stress, natural keratin detachment is delayed, and when the keratin is accumulated, the skin glossiness is reduced, and skin troubles such as acne can be accelerated. Alpha hydroxy acids, beta hydroxy acids, polyhydroxy acids and the like are known as organic acids promoting the exfoliation of the skin.

그러나, 유기산을 그대로 피부에 적용하는 경우 피부자극을 야기할 수 있는 문제가 있어 민감한 피부 및 트러블 피부에서 소비자가 원하는 효능을 제공하기 어려운 문제가 있다.However, when the organic acid is applied to the skin as it is, there is a problem that it may cause skin irritation, so that there is a problem that it is difficult to provide the effect desired by the consumer in sensitive skin and troublesome skin.

따라서, 상기 문제점들을 해결하여 유기산에 의한 자극이 적고, 내/외적 원인으로 인한 피부 pH 변화를 지속적으로 완화시킬 수 있는 새로운 제형이 필요하다.
Accordingly, there is a need for a novel formulation that can solve the above problems, reduce irritation caused by organic acids, and continuously alleviate changes in skin pH due to internal / external causes.

Journal of Investigative Dermatology, 2847-2856, 127, 2007Journal of Investigative Dermatology, 2847-2856, 127, 2007 Journal of Investigative Dermatology, 1824-1835, 129, 2009Journal of Investigative Dermatology, 1824-1835, 129, 2009

본 발명은 유기산에 의한 자극이 적고, 내/외적 원인으로 인한 피부 pH 변화를 지속적으로 완화시킬 수 있는 pH 완충 시스템을 갖는 유화 화장료 조성물을 제공하는 것을 목적으로 한다.
It is an object of the present invention to provide a cosmetic composition for emulsification having a pH buffering system which is less irritating by organic acids and can continuously alleviate changes in skin pH due to internal / external causes.

상기 과제를 해결하기 위한 수단으로서, 본 발명은 pH 완충 시스템을 갖는 유화 화장료 조성물을 제공한다. As means for solving the above problems, the present invention provides an emulsified cosmetic composition having a pH buffer system.

본 발명에서, pH 완충 시스템은 산(acid)을 함유하는 완충 용액을 포함하는 것을 특징으로 한다. In the present invention, the pH buffer system is characterized in that it comprises a buffer solution containing an acid.

따라서, 본 발명은 산(acid)을 함유하는 완충 용액을 포함하고, pH가 3 내지 5인 화장료 조성물을 제공한다.Accordingly, the present invention provides a cosmetic composition comprising a buffer solution containing an acid and having a pH of 3 to 5. [

상기 과제를 해결하기 위한 또 다른 수단으로서, 본 발명은As another means for solving the above problems,

산(acid)을 함유하는 완충 용액을 포함하고, pH가 3 내지 5인 피부 보습 및 피부 pH 변화 완화용 화장료 조성물을 제공한다.
The present invention provides a cosmetic composition comprising a buffer solution containing an acid and having a pH of 3 to 5 for alleviating skin moisturization and skin pH change.

본 발명에 따른 pH 완충 시스템을 갖는 화장료 조성물은 유기산에 의한 자극이 적고, 내/외적 원인으로 인한 피부 pH 변화를 지속적으로 완화시킬 뿐만 아니라 각질박리 및 피부장벽 개선을 통해 노화, 여드름 및 아토피를 포함하는 트러블 피부상태를 현저하게 개선할 수 있다.
The cosmetic composition with a pH buffer system according to the present invention is less irritating by organic acids, and continuously alleviates changes in skin pH due to internal / external causes, as well as aging, acne and atopy through exfoliation and skin barrier improvement It is possible to remarkably improve the trouble state of the skin.

이하, 본 발명의 구성을 구체적으로 설명한다.Hereinafter, the configuration of the present invention will be described in detail.

본 발명은 pH 완충 시스템을 갖는 유화 화장료 조성물을 제공한다. The present invention provides an emulsified cosmetic composition having a pH buffer system.

본 발명에서, pH 완충 시스템은 산(acid)을 함유하는 완충 용액을 포함하는 것을 특징으로 한다. In the present invention, the pH buffer system is characterized in that it comprises a buffer solution containing an acid.

따라서, 본 발명은 산(acid)을 함유하는 완충 용액을 포함하고, pH가 3 내지 5인 유화 화장료 조성물을 제공한다.Accordingly, the present invention provides an emulsified cosmetic composition comprising a buffer solution containing an acid and having a pH of 3 to 5. [

본 발명의 유화 화장료 조성물은 잘 융합되지 않는 2 이상의 액체의 혼합물인 에멀젼이기만 하면 되고, 그 타입은 특별히 제한되지 않는다. 예를 들어, 본 발명의 유화 화장료 조성물은 수중유형(oil in water; O/W) 또는 유중수형(water in oil; W/O) 타입일 수 있다. 또한, 수중유중수형(Water in oil in water; W/O/W) 또는 유중수중유형(Oil in water in oil; O/W/O)등의 다중 에멀젼 타입이어도 무방하다.The emulsified cosmetic composition of the present invention is not particularly limited as long as it is an emulsion which is a mixture of two or more liquids which are not well fused. For example, the emollient cosmetic composition of the present invention may be of oil in water (O / W) or water in oil (W / O) type. It is also possible to use multiple emulsion types such as water in oil in water (W / O / W) or oil in water in oil (O / W / O).

한 구체예에서, 본 발명의 유화 화장료 조성물은 수중유형일 수 있다. 수중유형 유화 화장료 조성물은 오일과 왁스 등으로 이루어진 유상이 친수성과 친유성을 분자안에 동시에 가지고 있는 계면활성제 분자에 의해 에멀전 구조를 형성하여 정제수, 폴리올, 점증제 등으로 이루어진 수상에 분산되어 있는 형태로, 가용화 제형에 비해 보습지속력과 피부 유연감 등이 뛰어나, 아토피를 비롯한 트러블이 발생한 피부의 지속적인 개선에 유리한 장점이 있다. In one embodiment, the emollient cosmetic composition of the present invention may be of the submerged type. The underwater type emulsion cosmetic composition is characterized in that an oil phase composed of oil and wax forms an emulsion structure by a surfactant molecule having both hydrophilic and lipophilic properties in the molecule and is dispersed in water phase composed of purified water, polyol, Compared to solubilized formulations, they have excellent moisture retention and skin abundance, which is advantageous for continuous improvement of skin including trouble such as atopy.

완충 용액은 외부로부터 어느 정도의 산이나 염기를 가하여도 이에 크게 영향을 받지 않고 수소이온 농도를 일정하게 유지하여, 용액의 pH가 일정하게 유지되는 용액을 말한다. 본 발명의 완충 용액은 산을 함유함으로써, 전체 화장료 조성물의 pH가 3 내지 5로 유지될 수 있도록 한다.A buffer solution is a solution in which the pH of the solution is kept constant by keeping the hydrogen ion concentration constant without being greatly affected by the addition of a certain amount of acid or base from the outside. The buffer solution of the present invention contains an acid so that the pH of the entire cosmetic composition can be maintained at 3 to 5.

본 발명에서 pH의 범위는 화장품 시험방법 중 pH 시험법으로 측정하였을 때의 pH를 의미하는 것으로, 본 발명의 화장료 조성물은 pH가 3 내지 5임을 특징으로 한다. pH 3 미만의 경우 피부 자극의 원인이 될 수 있으며, pH 5 초과시 피부 pH 변화를 완화하는 효과가 미약하다.In the present invention, the pH range refers to the pH measured by the pH test method in the cosmetic test method, and the cosmetic composition of the present invention has a pH of 3 to 5. If the pH is less than 3, it may cause skin irritation. If the pH is more than 5, the effect of alleviating the skin pH change is insufficient.

본 발명의 일 예에서, 산은 전체 조성물 100 중량부 대비 0.1 내지 3.0 중량부로 포함될 수 있다. 산의 함량이 상기 범위를 만족할 때, 피부에 자극이 없으면서도 조성물의 pH를 pH 3 내지 5로 지속적으로 유지할 수 있다. In one example of the present invention, the acid may be contained in an amount of 0.1 to 3.0 parts by weight based on 100 parts by weight of the total composition. When the content of the acid satisfies the above range, the pH of the composition can be maintained at a pH of 3 to 5 continuously without irritation to the skin.

한 구체예에서, 완충 용액은 유기산 및 그 짝염기를 포함하거나, 유기산 및 pH 조절제를 포함할 수 있다. 유기산과 그의 짝염기, 또는 유기산과 pH 조절제를 포함함으로써, pH를 일정하게 유지할 수 있다.In one embodiment, the buffer solution comprises an organic acid and its conjugated base, or may comprise an organic acid and a pH adjusting agent. By including an organic acid and its conjugated base, or an organic acid and a pH adjusting agent, the pH can be kept constant.

한 구체예에서, 유기산은 이에 제한되는 것은 아니나, 시트르산, 락트산, 말산, 글리콜산, 타르타르산, 살리실산, 아세트산, 프로피온산, 글루코노락톤, 락토바이온산, 이들의 혼합물 및 이들의 유도체로 이루어진 군으로부터 하나 이상 선택되는 것일 수 있다.In one embodiment, the organic acid is selected from the group consisting of citric, lactic, malic, glycolic, tartaric, salicylic, acetic, propionic, gluconolactone, lactobionic, mixtures thereof and derivatives thereof, Or more.

한 구체예에서, pH 조절제는 조성물의 pH를 pH 3 내지 5로 유지시켜 줄 수 있는 물질이면 제한 없이 사용 가능하다. pH 조절제는 공지의 완충제를 제한 없이 이용할 수 있으며, 예를 들어, 트로메타민, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), HEPPS(3-[4-(2-hydroxyethyl)piperazin-1-yl]propane-1-sulfonic acid), TAPS(3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propane-1-sulfonic acid), MES(2-(N-morpholino)ethanesulfonic acid), TES(2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid), BES(N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid), TAPSO(3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-hydroxypropane-1-sulfonic acid), POPSO(Piperazine-N,N′-bis(2-hydroxypropanesulfonic acid)), HEPPSO(N-(Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid), DIPSO(3-(N,N-Bis[2-hydroxyethyl]amino)-2-hydroxypropanesulfonic acid), 글리신아미드(glycinamide), 바이신(Bicine), 트리신(Tricine), 아세트아미도글리신(Acetamidoglycine), MOPS(3-morpholinopropane-1-sulfonic acid), 이들의 혼합물 및 이들의 유도체로 이루어진 군으로부터 선택되는 하나 이상일 수 있다.In one embodiment, the pH adjusting agent can be used without limitation as long as it can maintain the pH of the composition at a pH of 3 to 5. [ The pH adjusting agent may be selected from known buffers without limitation, for example, tromethamine, HEPES (4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid), HEPPS (3- [4- (2-hydroxyethyl) -1-yl] propane-1-sulfonic acid), TAPS (3 - [[1,3-dihydroxy-2- (hydroxymethyl) propan- (2-hydroxyethyl) propane-2-yl] amino] ethanesulfonic acid), BES (N-morpholino) ethanesulfonic acid), TES (2 - [[ 2-aminoethanesulfonic acid), TAPSO (3 - [[1,3-dihydroxy-2- (hydroxymethyl) propan-2-yl] amino] -2-hydroxypropane- 2-hydroxypropanesulfonic acid), HEPPSO (N- (hydroxyethyl) piperazine-N'-2-hydroxypropanesulfonic acid), DIPSO (3- acid, glycinamide, Bicine, Tricine, Acetamidoglycine, MOPS (3-morpholinopropane-1-sulfonic acid), mixtures thereof and derivatives thereof It may be at least one selected from the group consisting of.

한 구체예에서, 유기산 및 그 짝염기는 1: 0.2 내지 1:1의 중량비로 포함될 수 있다. 유기산 및 그 짝염기의 함량이 상기 범위를 만족할 때, 피부에 자극이 없으면서도 조성물의 pH를 pH 3 내지 5로 지속적으로 유지할 수 있다. In one embodiment, the organic acid and its conjugate base may be included in a weight ratio of 1: 0.2 to 1: 1. When the content of the organic acid and its conjugated base is within the above range, the pH of the composition can be maintained at a pH of 3 to 5 continuously without irritation to the skin.

한 구체예에서, 유기산 및 pH 조절제는 1: 0.2 내지 1:1의 중량비로 포함될 수 있다. 유기산 및 pH 조절제의 함량이 상기 범위를 만족할 때, 피부에 자극이 없으면서도 조성물의 pH를 pH 3 내지 5로 지속적으로 유지할 수 있다. In one embodiment, the organic acid and the pH adjusting agent may be included in a weight ratio of 1: 0.2 to 1: 1. When the content of the organic acid and the pH adjuster satisfies the above range, the pH of the composition can be maintained at a pH of 3 to 5 continuously without irritation to the skin.

하기 실시예에서 확인할 수 있는 바와 같이, 본 발명의 유화 화장료 조성물은 피부 보습 효과가 우수하며, 피부 pH 변화를 지속적으로 완화시킬 수 있다. 피부의 수분 보유능을 향상시키고, 내/외부적 원인에 의한 피부의 pH 상승 작용을 완화시켜, 피부를 pH 3 내지 5의 정상 범위로 유지시킴에 따라, pH 변화에 의한 다양한 피부 증상을 완화 개선시킬 수 있다. 예를 들어, 피부결을 매끄럽게 하고, 피부 노화, 여드름, 아토피 증상 등을 완화시킬 수 있다. 뿐만 아니라, 피부 자극감을 현저히 낮춤에 따라 사용자의 사용 만족도를 향상시킬 수 있다. 따라서, 본 발명의 화장료 조성물은 피부 보습용, pH 변화 완화용 화장료의 제형으로 제공할 수 있다. As can be seen from the following Examples, the emulsified cosmetic composition of the present invention has excellent skin moisturizing effect and can continuously alleviate changes in skin pH. It is possible to improve the water retention ability of the skin and alleviate the pH synergy of the skin caused by internal / external causes and maintain the skin in the normal range of pH 3 to 5, thereby alleviating various skin symptoms due to the pH change . For example, it can smooth skin texture, alleviate skin aging, acne, and atopic symptoms. In addition, the user's satisfaction with the use can be improved as the skin irritation is significantly lowered. Therefore, the cosmetic composition of the present invention can be provided as a formulation of a cosmetic for moisturizing skin and alleviating pH change.

본 발명의 유화 화장료 조성물을 유효성분으로 함유하여 제조되는 화장품은 일반적인 유화 제형 또는 가용화 제형의 형태로 제조할 수 있다. 예컨대, 유연 화장수 또는 영양 화장수 등과 같은 화장수(스킨); 훼이셜 로션 또는 바디로션 등과 같은 유액; 영양 크림, 수분 크림 또는 아이 크림 등과 같은 크림; 에센스; 화장연고; 스프레이; 젤; 팩; 선 스크린; 메이크업 베이스; 액체 타입, 고체 타입 또는 스프레이 타입 등의 파운데이션; 파우더; 클렌징 크림, 클렌징 로션, 클렌징 오일과 같은 메이크업 제거제; 클렌징 폼, 비누, 바디 워쉬 등과 같은 세정제 등의 제형을 가질 수 있다. The cosmetics prepared by containing the emulsified cosmetic composition of the present invention as an active ingredient can be prepared in the form of a general emulsified formulation or a solubilized formulation. For example, lotions (skins) such as soft lotion or nutrition lotion; Lotion such as facial lotion or body lotion; Creams such as nutritional creams, moisture creams or eye creams; essence; Makeup ointment; spray; Gel; pack; Sunscreen; Makeup base; A foundation such as a liquid type, a solid type or a spray type; powder; Makeup removers such as cleansing creams, cleansing lotions, cleansing oils; Detergents such as cleansing foams, soaps, body wash, and the like.

또한 상기 화장품은 지방 물질, 유기 용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 유화제, 비이온형 유화제, 충전제, 금속이온봉쇄제, 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 활성제, 친유성 활성제 또는 지질 소낭 등 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.
The cosmetic composition may further contain at least one selected from the group consisting of fatty substances, organic solvents, solubilizers, thickening agents, gelling agents, softening agents, antioxidants, suspending agents, stabilizers, foaming agents, fragrances, surfactants, water, Such as fillers, sequestering agents, chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic active agents, lipophilic active agents or lipid vesicles .

이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

[[ 실시예Example ]]

실시예Example 1 내지 3 1 to 3

하기 표 1의 조성에 따라 오일, 왁스 및 계면활성제를 가하여 70℃ 내지 75℃로 가열 용해 하여 유상을 제조하였다. pH 완충 용액으로 유기산 및 그 짝염기, 또는 유기산 및 유기버퍼 화합물을 사용하였다. pH 완충 용액, 폴리올 및 점증제 등을 정제수에 분산시켜 70℃ 내지 75℃로 가열한 수상에 상기 유상을 첨가하였다. 그 후, 호모믹서 1500 내지 3500 rpm 조건하에서 10분간 교반하고 50℃에서 첨가제를 투입하였다. 그리고 나서, 5분간 교반하여 30℃까지 냉각시켜 pH 완충 시스템을 갖는 수중유형 유화 화장료 조성물을 제조하였다.Oil, wax and a surfactant were added according to the composition shown in the following Table 1 and heated to dissolve at 70 캜 to 75 캜 to prepare an oil phase. Organic acids and their conjugate bases, or organic acids and organic buffer compounds were used as pH buffer solutions. pH buffer solution, polyol and thickeners were dispersed in purified water and the oil phase was added to the water phase heated to 70 to 75 ° C. Thereafter, the homomixer was stirred for 10 minutes under the condition of 1500 to 3500 rpm, and the additive was added at 50 占 폚. Then, the mixture was stirred for 5 minutes and cooled to 30 캜 to prepare an underwater type emulsion cosmetic composition having a pH buffer system.

Figure pat00001
Figure pat00001

비교예Comparative Example 1 내지 6 1 to 6

하기 표 2의 조성에 따라 실시예 1 내지 6과 동일한 방법으로 pH 완충 시스템이 없는 수중유형 화장료 조성물을 제조하였다.An underwater type cosmetic composition without a pH buffer system was prepared in the same manner as in Examples 1 to 6 according to the composition shown in Table 2 below.

Figure pat00002

Figure pat00002

[[ 실험예Experimental Example ]]

실험예Experimental Example 1: pH 및 경도 확인 1: Check pH and hardness

상기 실시예 및 비교예의 pH 및 경도를 확인하였다. pH는 화장품 시험방법 중 pH 시험법에 따라 측정하였다. 요약하면, 각 실시예 및 비교예의 조성물 2g을 정제수 30ml로 희석하고, 기능성화장품 시험방법에 따라 F-52 pH 미터(HORIBA社)를 이용하여 pH를 측정하였다.The pH and hardness of the above Examples and Comparative Examples were confirmed. The pH was measured by the pH test method in the cosmetic test method. In summary, 2 g of each of the compositions of the Examples and Comparative Examples was diluted with 30 ml of purified water, and the pH was measured using an F-52 pH meter (HORIBA) according to the functional cosmetic test method.

경도는 RTC-3005D 경도계(RHEOTECH社)를 사용하여, 측정바가 2cm/min 속도로 시료를 25mm 깊이로 눌렀을 때의 저항력을 측정하였다. 그 결과를, 표 3에 나타내었다.The hardness was measured by using a RTC-3005D durometer (RHEOTECH), and the resistance of the sample when the sample was pressed at a depth of 25 mm at a rate of 2 cm / min was measured. The results are shown in Table 3.

Figure pat00003

Figure pat00003

실험예Experimental Example 2: pH 완충 시스템 종류 및 유무에 따른 피부 pH 변화 및 지속력 비교 2: Comparison of skin pH change and persistence according to pH buffer system type and presence

pH 완충 시스템의 종류 및 유무에 따른 피부 pH 변화 완화 효과 및 지속력을 비교하기 위해 실시예 1 내지 3 및 비교예 1 내지 2의 조성물을 사용하였다. 온도 25℃, 상대습도 70%로 유지된 항온 항습실에서 경증의 아토피를 겪고 있는 남녀 20명을 대상으로 실험 직전 환부의 피부 pH를 측정하고, 피부 pH를 인위적으로 상승시키기 위해 pH 10의 폼클렌저로 환부를 클렌징한 직후 피부 pH를 측정하였다. 각각의 제형을 바른 뒤 30분 단위로 240분까지의 피부 pH를 측정해 평균값으로 비교하였다. 피부 pH는 피부 pH 측정장치(Skin-pH-Meter PH905, Courage + Khazaka electronic GmbH사)를 이용하여 측정하였으며, 그 결과를 표 4에 나타내었다.The compositions of Examples 1 to 3 and Comparative Examples 1 to 2 were used to compare the skin pH change relieving effect and the sustainability depending on the type and the presence of the pH buffer system. 20 men and women undergoing mild atopy in a temperature and humidity room maintained at 25 ℃ and 70% relative humidity were used to measure the skin pH of the lesion immediately before the experiment. To increase the skin pH artificially, a foam cleanser The skin pH was measured immediately after cleansing the lesion. After each formulation was applied, the skin pH was measured up to 240 minutes in 30-minute increments and compared with the average value. Skin pH was measured using a skin pH meter (Skin-pH-Meter PH905, Courage + Khazaka electronic GmbH), and the results are shown in Table 4.

Figure pat00004
Figure pat00004

상기 표 4의 결과에서 알 수 있듯이, 실시예 1 내지 2의 경우 피부 pH를 빠르게 정상화 시키는 것을 확인할 수 있으며, 측정시간 동안 유지되는 것을 확인할 수 있다. 실시예 3의 경우 완충능(Buffer capacity)의 차이로 인해 도포 180분 까지만 피부 pH가 정상화되어 유지되었다. 그러나, 비교예 1의 경우 제형을 바른 뒤 120분이 지나도 실험전의 pH로 회복되지 않는 것을 확인할 수 있으며, 비교예 2의 경우, 제형을 바른 뒤 빠르게 pH 회복이 이루어지나 90분 후 실험전의 pH로 되돌아가는 것을 확인할 수 있다. As can be seen from the results of Table 4, it can be confirmed that the skin pH is rapidly normalized in Examples 1 and 2 and maintained for the measurement time. In the case of Example 3, the skin pH was maintained normalized for up to 180 minutes due to the difference in buffer capacity. However, in the case of Comparative Example 1, it was confirmed that the pH did not recover before the experiment even after 120 minutes from the application of the formulation. In the case of Comparative Example 2, the pH was recovered quickly after the formulation was applied. .

이는, 본 발명의 화장료 조성물은 pH 완충 시스템을 가짐으로써 피부의 pH 변화를 지속적으로 완화시킬 수 있음을 의미한다.
This means that the cosmetic composition of the present invention has a pH buffer system, thereby continuously alleviating the pH change of the skin.

실험예Experimental Example 3: pH 완충 시스템 유무에 따른  3: With or without pH buffer system 피부결Skin texture , , 각질박리Exfoliation 개선, 피부 수분 보유능 및 피부자극 비교 Improvement, skin moisture retention ability and skin irritation

pH 완충 시스템 유무에 따른 피부결, 각질박리 개선 및 피부보습 개선 효능을 비교하기 위하여 버퍼 시스템을 달리한 실시예 1 및 비교예 1 내지 6을 사용하였다. 50대 성인 남녀 20명을 대상으로 실험직전 피부결 및 피부 pH를 측정하고 평소 사용방법대로 크림을 얼굴에 4주 동안 사용하게 하고 2주마다 측정하여 시험전 대비 개선율로 환산하여 비교하였다. In order to compare the skin effect, the improvement of the skin exfoliation and the skin moisturizing effect according to the presence or absence of the pH buffer system, Example 1 and Comparative Examples 1 to 6 in which buffer systems were different were used. Twenty adults in their 50s were tested for skin texture and skin pH just before the experiment. The cream was applied to the face for 4 weeks according to the usual method.

사용만족도는 4주 사용 후 5점 만점 척도로 설문을 통해 확인하였다. 온도 25℃, 상대습도 70%로 유지된 항온 항습실에서 피부결 변화는 PRIMOS High Resolution Image Analyser를 이용하여 측정하였다.Satisfaction with use was confirmed by questionnaire with 4 out of 5 points. The change of skin texture was measured using a PRIMOS High Resolution Image Analyzer in a constant temperature and humidity room maintained at 25 ℃ and 70% relative humidity.

각질박리 개선효과는 시험부위를 DHA로 착색한 후 (Chromameter CR300, 독일 CK Electronic)으로 Luminosity 값의 변화를 시료를 사용하지 않은 시험부위와 시료를 사용한 부위를 비교하여 평가하였다.The improvement of the exfoliation was evaluated by comparing the Luminosity value of the test area with that of the test site after using the DHA (Chromameter CR300, Germany CK Electronic).

피부 수분 함량은 피부 수분함량 측정장치(Corneometer CM825, 독일 CK Electronic)를 이용하여 측정하였다. 결과값은 시험전 대비 개선율로 환산하여 비교하였다. Skin moisture content was measured using a skin moisture content measuring device (Corneometer CM825, CK Electronic, Germany). The results were compared with the improvement rate before the test.

피부자극도는 화장품평가/분석법 평-29에 근거하여 24시간 첩포시험을 실시하였으며, 자극지수(PII)는 다음과 같다.Skin irritation test was conducted for 24 hours on the basis of Cosmetics Evaluation / Analysis Method-29. The stimulus index (PII) was as follows.

Figure pat00005
Figure pat00005

그 결과를 하기 표 5에 나타내었다.The results are shown in Table 5 below.

Figure pat00006
Figure pat00006

상기 표 5의 결과에서 알 수 있듯이, pH 완충 시스템을 갖는 실시예 1이 비교예 1 내지 6과 비교하여 현저한 피부결 개선, 피부 수분 함량 개선 및 각질박리 개선을 보이며 노화피부의 개선에 도움이 되는 것을 확인할 수 있다.As can be seen from the results of Table 5, Example 1 having a pH buffer system exhibited remarkable skin texture improvement, skin moisture content improvement and exfoliation improvement as compared with Comparative Examples 1 to 6, .

비교예 2 내지 5의 경우 피부결, 피부수분함량 및 각질박리가 일부 개선되나 그 정도가 현저히 낮으며, 비교예 4 및 비교예 6의 경우 피부자극이 높아 민감한 피부의 사용자에게 부적합하며, 사용자 만족도 또한 낮게 나오는 확인할 수 있었다.In Comparative Examples 2 to 5, the skin texture, the skin moisture content and the exfoliation were somewhat improved but the degree was remarkably low. In Comparative Example 4 and Comparative Example 6, skin irritation was high and it was not suitable for sensitive skin users. It was also able to identify coming out low.

이는 본 발명의 pH 완충 시스템이 피부결 개선, 피부 수분 함량 개선, 각질 박리 개선에 효과적임을 의미한다. 또한, pH 완충 시스템에 함유되는 유기산의 농도 및 유기산 및 그 짝염기 또는 유기 버퍼화합물의 함량비가 상기 효과를 지속적으로 유지하는 데 중요함을 의미한다.
This means that the pH buffer system of the present invention is effective for skin texture improvement, skin moisture content improvement, and exfoliation improvement. It also means that the concentration of the organic acid contained in the pH buffer system and the ratio of the organic acid and its conjugate base or the content of the organic buffer compound are important for maintaining the above effect continuously.

실험예Experimental Example 4: pH 완충 시스템 유무에 따른  4: With or without pH buffer system 경피Percutaneous 수분 손실량( Water loss ( TEWLTEWL ), 아토피 개선 및 사용 만족도 비교), Improvement of atopy and satisfaction of use

pH 완충 시스템 유무에 따른 아토피 환부의 피부장벽 복구 및 증상 개선효능을 비교하기 위하여 버퍼 시스템을 달리한 실시예 1 및 비교예 1 내지 4를 사용하였다. In order to compare the skin barrier restoration and symptom improvement efficacy of atopic dermatitis with or without a pH buffer system, Example 1 and Comparative Examples 1 to 4, which are different from the buffer system, were used.

경증 아토피를 겪고 있는 남녀 20명을 대상으로 실험직전 경피 수분 손실량을 측정하고 평소 사용방법대로 환부에 크림을 4주동안 사용하게 하였다. 온도 25℃, 상대습도 70%로 유지된 항온 항습실에서 경피 수분 손실량은 Tewameter(TM300, 독일 CK Electronic)를 이용하여 2주 마다 측정하였으며, 결과값은 시험전 대비 개선율로 환산하여 비교하였다.Twenty men and women suffering from mild atopy were examined for percutaneous water loss immediately before the experiment and the cream was used for 4 weeks at the affected site as usual. The transdermal water loss was measured every 2 weeks using a Tewameter (TM300, Germany CK Electronic) in a constant temperature and humidity chamber maintained at a temperature of 25 ° C and a relative humidity of 70%.

아토피 증상 개선은 육안 확인을 통하여 증상 개선 인원 비율로 환산하였으며 4주 사용 후 5점 만점 척도로 설문을 통해 확인하였다.The improvement of atopic symptoms was visualized by visual confirmation, and it was confirmed by the questionnaire with the scale of 5 points after 4 weeks of use.

사용 만족도는 4주 사용 후 5점 만점 척도로 설문을 통해 확인하였다. Satisfaction with use was confirmed by questionnaire with 4 out of 5 points.

그 결과를 표 6에 나타내었다.The results are shown in Table 6.

Figure pat00007
Figure pat00007

상기 표 6의 결과에서 알 수 있듯이, pH 완충 시스템을 갖는 실시예 1이 비교예 1 내지 4와 비교하여 현저한 경피 수분 손실량(TEWL)으로 측정한 피부 장벽 개선 효과 및 아토피 증상 개선 효과를 나타내었다. 실시예 1이 아토피 개선 인원 비율이 현저히 높았고, 아토피개선 만족도 및 사용만족도 또한 높은 것을 확인할 수 있다. 비교예 2 내지 4의 경우 경피 수분 손실량 및 육안으로 확인한 증상 개선이 일부 있으나 그 정도가 현저히 낮음을 확인할 수 있다.As can be seen from the results of Table 6, Example 1 having the pH buffer system showed a skin barrier improvement effect and an atopic symptom improvement effect, which were measured by a remarkable transdermal water loss (TEWL) as compared with Comparative Examples 1 to 4. It can be confirmed that the ratio of atopy-improved persons in Example 1 was remarkably high, and the atopy improvement satisfaction and the use satisfaction were also high. In the case of Comparative Examples 2 to 4, the amount of transdermal water loss and visual symptom improvement were noticed to some extent, but the degree was remarkably low.

이는, 본 발명의 pH 완충 시스템이 피부장벽 개선 효과 및 아토피 증상 개선 효과가 우수하여, 피부장벽 개선 및 아토피 증상 완화에 사용될 수 있음을 의미한다. 또한, pH 완충 시스템에 함유되는 유기산의 농도 및 유기산 및 그 짝염기 또는 유기 버퍼화합물의 함량비가 상기 효과를 지속적으로 유지하는 데 중요함을 알 수 있었다.
This means that the pH buffer system of the present invention is excellent in skin barrier improvement effect and atopic symptom improvement effect and can be used for skin barrier improvement and atopic symptom relief. It was also found that the concentration of the organic acid contained in the pH buffer system and the ratio of the organic acid and its conjugate base or the content of the organic buffer compound are important for maintaining the above effect continuously.

Claims (8)

산(acid)을 함유하는 완충 용액을 포함하고, pH가 3 내지 5인 유화 화장료 조성물.
1. A cosmetic composition for emulsification comprising a buffer solution containing an acid and having a pH of 3 to 5.
제1항에 있어서,
산은 전체 조성물 100 중량부 대비 0.1 내지 3.0 중량부로 포함되는 것인 유화 화장료 조성물.
The method according to claim 1,
Wherein the acid is contained in an amount of 0.1 to 3.0 parts by weight based on 100 parts by weight of the total composition.
제1항에 있어서,
완충 용액은 유기산 및 그 짝염기를 포함하는 것인 유화 화장료 조성물.
The method according to claim 1,
Wherein the buffer solution comprises an organic acid and its conjugated base.
제1항에 있어서,
완충 용액은 유기산 및 pH 조절제를 포함하는 것인 유화 화장료 조성물.
The method according to claim 1,
Wherein the buffer solution comprises an organic acid and a pH adjusting agent.
제2항 또는 제3항에 있어서,
유기산은 시트르산, 락트산, 말산, 글리콜산, 타르타르산, 살리실산, 아세트산, 프로피온산, 글루코노락톤, 락토바이온산, 이들의 혼합물 및 이들의 유도체로 이루어진 군으로부터 하나 이상 선택되는 것인 유화 화장료 조성물.
The method according to claim 2 or 3,
Wherein the organic acid is at least one selected from the group consisting of citric acid, lactic acid, malic acid, glycolic acid, tartaric acid, salicylic acid, acetic acid, propionic acid, gluconolactone, lactobionic acid, mixtures thereof and derivatives thereof.
제3항에 있어서,
pH 조절제는 트로메타민, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), HEPPS(3-[4-(2-hydroxyethyl)piperazin-1-yl]propane-1-sulfonic acid), TAPS(3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propane-1-sulfonic acid), MES(2-(N-morpholino)ethanesulfonic acid), TES(2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid), BES(N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid), TAPSO(3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-2-hydroxypropane-1-sulfonic acid), POPSO(Piperazine-N,N′-bis(2-hydroxypropanesulfonic acid)), HEPPSO(N-(Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid), DIPSO(3-(N,N-Bis[2-hydroxyethyl]amino)-2-hydroxypropanesulfonic acid), 글리신아미드(glycinamide), 바이신(Bicine), 트리신(Tricine), 아세트아미도글리신(Acetamidoglycine), MOPS(3-morpholinopropane-1-sulfonic acid), 이들의 혼합물 및 이들의 유도체로 이루어진 군으로부터 선택되는 하나 이상인 유화 화장료 조성물.
The method of claim 3,
The pH adjusting agent may be selected from the group consisting of tromethamine, HEPES (4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid), HEPPS (3- [4- (2- (N-morpholino) ethanesulfonic acid), TES (2- [3-amino- 2-aminoethanesulfonic acid), BES (N, N-bis (2-hydroxyethyl) -2-aminoethanesulfonic acid), TAPSO (3 - [[ , 2-hydroxypropanesulfonic acid), POPSO (Piperazine-N, N'-bis (2-hydroxypropanesulfonic acid)), HEPPSO (N - (Hydroxyethyl) piperazine-N'-2-hydroxypropanesulfonic acid), DIPSO (3- (N-Bis [2- hydroxyethylamino] -2- hydroxypropanesulfonic acid, glycinamide, Bicine) , At least one selected from the group consisting of tricine, acetamidoglycine, 3-morpholinopropane-1-sulfonic acid (MOPS), mixtures thereof, and derivatives thereof. / RTI >
제2항에 있어서,
유기산 및 그 짝염기는 1: 0.2 내지 1:1의 중량비로 포함되는 것인 유화 화장료 조성물.
3. The method of claim 2,
Wherein the organic acid and its conjugated base are contained in a weight ratio of 1: 0.2 to 1: 1.
제3항에 있어서,
유기산 및 pH 조절제는 1: 0.2 내지 1:1의 중량비로 포함되는 것인 유화 화장료 조성물.
The method of claim 3,
Wherein the organic acid and the pH adjusting agent are contained in a weight ratio of 1: 0.2 to 1: 1.
KR1020150035050A 2015-03-13 2015-03-13 Emulsified cosmetic composition having a pH buffer system KR102078140B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020150035050A KR102078140B1 (en) 2015-03-13 2015-03-13 Emulsified cosmetic composition having a pH buffer system
PCT/KR2016/002341 WO2016148434A1 (en) 2015-03-13 2016-03-09 Emulsion cosmetic composition having ph buffer system
CN201680015173.8A CN107427429B (en) 2015-03-13 2016-03-09 Emulsified cosmetic composition with pH buffer system
HK18103801.3A HK1244226A1 (en) 2015-03-13 2018-03-19 Emulsion cosmetic composition having ph buffer system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150035050A KR102078140B1 (en) 2015-03-13 2015-03-13 Emulsified cosmetic composition having a pH buffer system

Publications (2)

Publication Number Publication Date
KR20160109868A true KR20160109868A (en) 2016-09-21
KR102078140B1 KR102078140B1 (en) 2020-02-17

Family

ID=56919196

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150035050A KR102078140B1 (en) 2015-03-13 2015-03-13 Emulsified cosmetic composition having a pH buffer system

Country Status (4)

Country Link
KR (1) KR102078140B1 (en)
CN (1) CN107427429B (en)
HK (1) HK1244226A1 (en)
WO (1) WO2016148434A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190012412A (en) * 2017-07-27 2019-02-11 (주)엘지하우시스 Wallpaper with buffer
KR20200022646A (en) * 2018-08-23 2020-03-04 대구한의대학교산학협력단 Cosmetic composition comprising lactic acid and gluconolactone for enhancing skin barrier

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company Composition and method for improving the appearance of skin
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
CN115843238A (en) 2020-06-01 2023-03-24 宝洁公司 Method for improving penetration of vitamin b3 compounds into the skin
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN114557915A (en) * 2022-03-23 2022-05-31 伊美莱(广州)医疗技术有限公司 Toning lotion and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839165A (en) * 1986-02-06 1989-06-13 Beiersdorf Aktiengesellschaft Cosmetic agents for hair
WO2007001484A2 (en) * 2005-06-20 2007-01-04 Playtex Products, Inc. Non-irritating compositions
KR20110069729A (en) * 2009-12-17 2011-06-23 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 Mild leave-on skin care compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
JPS60158105A (en) * 1984-01-28 1985-08-19 Susumu Morita Acidic rinsing agent
JPH08119828A (en) * 1994-10-18 1996-05-14 Kanebo Ltd Cosmetic
US5932196A (en) * 1994-11-04 1999-08-03 The Procter & Gamble Company Buffered emulsion compositions containing actives subject to acid or base hydrolysis
FR2730928B1 (en) * 1995-02-23 1997-04-04 Oreal COMPOSITION BASED ON LIPIDIC VESICLES WITH ACIDIC PH AND USE THEREOF IN TOPICAL APPLICATION
US5976556A (en) * 1996-06-13 1999-11-02 Active Organics, Inc. Combination of acid protease enzymes and acidic buffers and uses thereof
US5935589A (en) * 1997-10-17 1999-08-10 Chesebrough-Pond's Usa Co. Stable cosmetic compositions with different pH emulsions
US6036963A (en) * 1998-02-26 2000-03-14 Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc. Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
CN102100647B (en) * 2009-12-16 2013-03-20 麦克森生物科技股份有限公司 Organic acid composition for removing dead skin and keratin of hand and foot and patch containing composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839165A (en) * 1986-02-06 1989-06-13 Beiersdorf Aktiengesellschaft Cosmetic agents for hair
WO2007001484A2 (en) * 2005-06-20 2007-01-04 Playtex Products, Inc. Non-irritating compositions
KR20110069729A (en) * 2009-12-17 2011-06-23 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 Mild leave-on skin care compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Investigative Dermatology, 1824-1835, 129, 2009
Journal of Investigative Dermatology, 2847-2856, 127, 2007

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190012412A (en) * 2017-07-27 2019-02-11 (주)엘지하우시스 Wallpaper with buffer
KR20200022646A (en) * 2018-08-23 2020-03-04 대구한의대학교산학협력단 Cosmetic composition comprising lactic acid and gluconolactone for enhancing skin barrier

Also Published As

Publication number Publication date
CN107427429B (en) 2021-09-07
HK1244226A1 (en) 2018-08-03
CN107427429A (en) 2017-12-01
KR102078140B1 (en) 2020-02-17
WO2016148434A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
KR102078140B1 (en) Emulsified cosmetic composition having a pH buffer system
Camargo Jr et al. Skin moisturizing effects of panthenol-based formulations
US20150359723A1 (en) Composition externally used for subacid skin and cosmetic material including same
BRPI0619269A2 (en) antibacterial composition for contact with mucosa or other oral cavity tissues, oral care composition, use of a scleroglucan, process for preparing a cosmetic or dermatological formulation, concentrate and method of reducing the number of bacteria and / or minimizing adhesion of bacteria in the oral mucosa
EP2819639B1 (en) Cosmetic or dermatological preparation for application on wet skin
Tasic‐Kostov et al. Lactobionic acid as antioxidant and moisturizing active in alkyl polyglucoside‐based topical emulsions: the colloidal structure, stability and efficacy evaluation
KR20100088580A (en) Personal care sunscreen compositions having reduced eye irritation
AU2005200381A1 (en) Cosmetic compositions with long lasting skin moisturizing properties
KR102312901B1 (en) Emulsified cosmetic composition with acidic pH comprising macro liquid crystal emulsion particle
Jeong et al. Analysis of electrical property changes of skin by oil‐in‐water emulsion components
KR102236418B1 (en) Cosmetic composition containing ceramide having a refreshing sensation
KR101532938B1 (en) Water-in-Oil Type Emulsified Cosmetic Composition Containing High Content Butter
Filipović et al. Alp Rose stem cells, olive oil squalene and a natural alkyl polyglucoside emulsifier: Are they appropriate ingredients of skin moisturizers-in vivo efficacy on normal and sodium lauryl sulfate-irritated skin?
KR102432885B1 (en) Cosmetic composition for anti-aging
EP2705828B1 (en) Quick-penetrating, soft skin care cream
AU2020405221B2 (en) Personal care compositions and methods for the same
WO2009044248A2 (en) Cosmetic and dermopharmaceutical compositions for skin barrier restoration and disorders prevention
KR100681705B1 (en) Water-in-oil type cosmetic composition comprising fatty alcohol and cellulose alkyl ether
KR102246863B1 (en) Skin cleansing cosmetic compositions containing modified starch for low-irritation and skin exfoliation
KR102065321B1 (en) Oil-in-water emulsion composition containing recrystallized particle and cosmetic composition comprising the same
CN110114056B (en) Cosmetic use of sarcodictyin
US10682301B2 (en) Use of 4-(3-ethoxy-4-hydroxyphenyl)alkylketone as a skin-soothing agent
JP4246150B2 (en) Skin cosmetic composition
JP6209350B2 (en) Acne control composition, external preparation for skin and cosmetics
JP2003238336A (en) Cosmetic composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant